Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
  1. Home
  2. Browse
  3. Renal & Urology
  4. Drug Use in Renal Insufficiency
  5. Endocrinology

Endocrinology

  • Benign Prostatic Hypertrophy (11)
  • Cystitis (3)
  • Drug-Induced Nephrotoxicity (90)
  • Drug Use in Renal Insufficiency (204)
    • Bone/Joint and Rheumatology (19)
    • Cardiology (86)
    • Endocrinology (43)
    • Gastroenterology (19)
    • Hematology/Oncology (5)
    • Infectious Diseases (48)
    • Men's Health (1)
    • Neurology/Psychiatry (15)
    • Women's Health (2)
  • Hyperkalemia (12)
  • Hypokalemia (1)
  • Hyponatremia (4)
  • Incontinence (5)
  • Kidney Disease (42)
  • Kidney Stones (13)
  • Nephrology (45)
  • Overactive Bladder (22)
  • Resources (60)
  • Urinary Retention (7)
  • UTIs (69)
  • Urine Drug Testing (14)
16 - 30 of 43 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Chart: Stepwise Treatment of Type 2 Diabetes (Canada) June 2018
Chart: Comparison of Blood Glucose Meters February 2018
Chart: Lancets and Lancet Devices February 2018
Article: Don't Rule Out Sulfonylureas for Type 2 Diabetes January 2018
Commentary: Calculating Renal Function in Adults December 2017
Algorithm: Initiation and Adjustment of Insulin Regimens for Type 2 Diabetes March 2017
Algorithm: Management of New-Onset Type 2 Diabetes October 2016
Article: Recommend Monitoring Kidney Function in Patients Starting an SGLT2 Inhibitor August 2016
PL Voices: Renal Effects of Diabetes Medications August 2016
Commentary: Clinical Use of Metformin in Special Populations June 2016
Article: Watch for Ketoacidosis With the "Flozins" July 2015
Article: Caution About Using Gliptins in Heart Failure Patients July 2015
Other: Canada Vigilance July 2015
Other: SGLT2 Inhibitors (Flozins) and Ketoacidosis/Urinary Tract Infections (Dec 2015) July 2015
Article: Invokana (in-vo-KAHN-uh, canagliflozin), as the first in a new class of oral drugs for type 2 diabetes July 2014
  • « Prev
  • 1
  • 2
  • 3
  • Next »
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved